Gilead Sciences
North America, California, United States, Foster City
Description
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Investor Profile
Gilead Sciences has made 70 investments, with 3 in the past 12 months and 63% as lead.
Stage Focus
- Grant (46%)
- Post Ipo Equity (19%)
- Series B (16%)
- Series A (6%)
- Corporate Round (6%)
- Series C (3%)
- Series Unknown (3%)
- Seed (1%)
- Undisclosed (1%)
Country Focus
- United States (97%)
- Belgium (1%)
- United Kingdom (1%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Industry Focus
- Health Care
- Biotechnology
- Non Profit
- Therapeutics
- Medical
- Pharmaceutical
- Clinical Trials
- Life Science
- Social
- Communities
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
